Literature DB >> 31447522

The Prevalence and Risk Factors Associated with Nasal Methicillin-Resistant Staphylococcus Aureus Colonization among Children in a Tertiary Hospital in Nigeria.

Kemi Elizabeth Tuta1,2, Abiola Olukemi Okesola1, Chukwuma David Umeokonkwo2,3.   

Abstract

BACKGROUND: Nasal methicillin-resistant Staphylococcus aureus (MRSA) colonization is of public health concern due to increased risk of developing invasive infections and the therapeutic challenges. This concern is more among the vulnerable group. We determined the prevalence and associated risk factors of MRSA nasal carriage among children in a tertiary hospital in Nigeria.
METHOD: We conducted a hospital-based, cross-sectional study among 300 children attending the outpatient clinic of a tertiary hospital recruited through systematic sampling technique. An interviewer-administered, structured questionnaire was used to obtain sociodemographic characteristics and exposure factors. Nasal swabs samples were collected and inoculated on mannitol salt agar and subcultured on nutrient agar to isolate Staphylococcus aureus. We used the conventional Polymerase Chain Reaction (PCR) technique to detect the presence of mecA gene for MRSA. We calculated the prevalence, prevalence odds ratio to determine risk factors for MRSA acquisition at 5% level of significance.
RESULTS: The median age was 1.7 years (6 months-16 years). Males accounted for 60.7%, and 75% of the participants were under 5 years. Staphylococcus aureus colonization was found in 36.3% of the participants while 5.3% of the participants had MRSA identified by detecting the mecA gene. History of recent surgery in the last six months was the only independent predictor of nasal MRSA colonization among the participants (aOR=12.5; 95%CI: 2.7-50.0.).
CONCLUSION: The high prevalence of MRSA colonization observed among the children in this study suggests the need to consider screening children with history of previous surgery as infection control and prevention intervention for MRSA.

Entities:  

Keywords:  Children; MRSA; Staphylococcus aureus

Mesh:

Year:  2019        PMID: 31447522      PMCID: PMC6689698          DOI: 10.4314/ejhs.v29i4.10

Source DB:  PubMed          Journal:  Ethiop J Health Sci        ISSN: 1029-1857


  21 in total

1.  The worldwide prevalence of methicillin-resistant Staphylococcus aureus.

Authors:  A Voss; B N Doebbeling
Journal:  Int J Antimicrob Agents       Date:  1995-04       Impact factor: 5.283

Review 2.  Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan.

Authors:  Chih-Jung Chen; Yhu-Chering Huang
Journal:  J Microbiol Immunol Infect       Date:  2005-12       Impact factor: 4.399

3.  High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections.

Authors:  Bradley W Frazee; Jeremy Lynn; Edwin D Charlebois; Larry Lambert; Derrick Lowery; Francoise Perdreau-Remington
Journal:  Ann Emerg Med       Date:  2005-03       Impact factor: 5.721

4.  Nasal carriage of Staphylococcus aureus and methicillin-resistant S aureus in the United States, 2001-2002.

Authors:  Arch G Mainous; William J Hueston; Charles J Everett; Vanessa A Diaz
Journal:  Ann Fam Med       Date:  2006 Mar-Apr       Impact factor: 5.166

5.  Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group.

Authors:  C von Eiff; K Becker; K Machka; H Stammer; G Peters
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

6.  Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

Authors:  Rachel J Gorwitz; Deanna Kruszon-Moran; Sigrid K McAllister; Geraldine McQuillan; Linda K McDougal; Gregory E Fosheim; Bette J Jensen; George Killgore; Fred C Tenover; Matthew J Kuehnert
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

7.  The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland.

Authors:  M Denton; B O'Connell; P Bernard; V Jarlier; Z Williams; A Santerre Henriksen
Journal:  J Antimicrob Chemother       Date:  2008-01-25       Impact factor: 5.790

8.  Associated risk factors and pulsed field gel electrophoresis of nasal isolates of Staphylococcus aureus from medical students in a tertiary hospital in Lagos, Nigeria.

Authors:  Solayide A Adesida; Olusegun A Abioye; Babajide S Bamiro; Bartholomew I C Brai; Stella I Smith; Kehinde O Amisu; Deborah U Ehichioya; Folasade T Ogunsola; Akitoye O Coker
Journal:  Braz J Infect Dis       Date:  2007-02       Impact factor: 1.949

9.  Methicillin-resistant-Staphylococcus aureus hospitalizations, United States.

Authors:  Matthew J Kuehnert; Holly A Hill; Benjamin A Kupronis; Jerome I Tokars; Steven L Solomon; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

10.  Colonization and infection of the respiratory tract: What do we know?

Authors:  Joan Robinson
Journal:  Paediatr Child Health       Date:  2004-01       Impact factor: 2.253

View more
  3 in total

1.  Nasal carriage of meticillin-resistant Staphylococcus aureus among children living with HIV attending Infectious Diseases Clinics in Kano, Nigeria.

Authors:  Aisha Habib Sadauki; Abdulhakeem Abayomi Olorukooba; Muhammad Shakir Balogun; Mahmood Muazu Dalhat; Hyelshilni Waziri; Mukhtar Muhammad Abdulaziz; Chukwuma David Umeokonkwo; Fatimah Hassan-Hanga; Kabir Sabitu
Journal:  Infect Prev Pract       Date:  2022-04-22

2.  Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Hospitalized Patients in Eastern Heilongjiang Province, China.

Authors:  Xueying Yang; Jing Zhao; Yong Wang; Jian Wu; Xiaohong Wang; Yuchao Wang; Yiru Zhang; Huiling Li
Journal:  Infect Drug Resist       Date:  2021-04-28       Impact factor: 4.003

3.  Clonal diversity and spatial dissemination of multi-antibiotics resistant Staphylococcus aureus pathotypes in Southwest Nigeria.

Authors:  Akinniyi Paul Akinduti; Joshua Adekunle Osiyemi; Temitope Temitayo Banjo; Oluwaseun Ejilude; Maged El-Ashker; Adewale Gideon Adeyemi; Yemisi Dorcas Obafemi; Patrick Omoregie Isibor
Journal:  PLoS One       Date:  2021-02-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.